Trevi Therapeutics TRVI
€ 2.77
0.17%
Quartalsbericht 2024-Q2
hinzugefügt 08.08.2024
Trevi Therapeutics Gewinn / Verlust 2011-2024 | TRVI
Gewinn / Verlust Jährlich Trevi Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
351 M | 119 M | 14.6 M | 55.3 M | 93.6 M | - | 2.32 B | 2.32 B | - | - | - | - | - |
Anteile |
99 M | 64.5 M | 22.8 M | 18.5 M | 17.8 M | - | 15.4 M | 15.4 M | - | - | - | - | - |
Kurshistorie |
3.54 | 1.84 | 0.638 | 2.98 | 4.98 | - | - | - | - | - | - | - | - |
Nettogewinn |
-29.1 M | -29.2 M | -33.9 M | -32.8 M | -26 M | -20.5 M | -12.9 M | - | - | - | - | - | - |
Umsatz |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-33.9 M | -29.9 M | -32.5 M | -32.5 M | -26.6 M | -18.4 M | - | - | - | - | - | - | - |
Zinsaufwendungen |
391 K | 1.16 M | 1.2 M | 456 K | - | 174 K | - | - | - | - | - | - | - |
EBITDA |
-33.8 M | -29.9 M | -32.4 M | -32.3 M | -26.6 M | -20.5 M | -8.19 M | - | - | - | - | - | - |
Betriebsaufwand |
33.9 M | 29.9 M | 32.5 M | 32.5 M | 26.6 M | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
10.2 M | 10.1 M | 9.49 M | 10.2 M | 7.31 M | 4.34 M | 2.14 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Trevi Therapeutics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
101 M | 99.5 M | 68.3 M | 99.3 M | 98.7 M | 98.6 M | 59.9 M | 68.9 M | 59.5 M | 30.8 M | 28.5 M | 21.6 M | 20.1 M | 19.4 M | 18.5 M | 18.1 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 10.6 M | 444 K | 439 K | 439 K | 439 K | 435 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-12.4 M | -10.9 M | - | -7.7 M | -7.14 M | -6.4 M | - | -8.27 M | -8.05 M | -7.33 M | - | -7.26 M | -9.79 M | -8.37 M | - | -32.8 M | -32.8 M | -32.8 M | - | -26.1 M | -26.1 M | -26.1 M | - | -20.5 M | -20.5 M | -20.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Einnahmen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-13.3 M | -11.9 M | - | -9.04 M | -8.38 M | -7.56 M | - | -8.4 M | -7.82 M | -7.02 M | - | -6.95 M | -9.17 M | -8.09 M | - | -7.24 M | -7.41 M | -8.64 M | - | -7.65 M | -7.42 M | -4.81 M | - | -4.96 M | -4.38 M | -3.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
1 K | 1 K | - | 3 K | 153 K | 231 K | - | 292 K | 295 K | 302 K | - | 303 K | 296 K | 294 K | - | 148 K | - | - | - | - | - | - | - | 174 K | 51 K | 123 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -11.9 M | - | - | - | -7.54 M | - | -8.38 M | -7.8 M | -7.01 M | - | -6.91 M | -9.14 M | -8.08 M | - | -7.21 M | -7.39 M | -8.63 M | - | -7.62 M | -7.4 M | -4.8 M | - | -4.95 M | -4.37 M | -3.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
13.3 M | 11.9 M | - | 9.04 M | 8.38 M | 7.56 M | - | 8.4 M | 7.82 M | 7.02 M | - | 6.95 M | 9.17 M | 8.09 M | - | 7.24 M | 7.41 M | 8.64 M | - | 7.65 M | 7.42 M | 4.81 M | - | 4.96 M | 4.38 M | 3.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
3.27 M | 3.1 M | - | 2.72 M | 2.54 M | 2.56 M | - | 2.64 M | 2.72 M | 2.38 M | - | 2.23 M | 2.67 M | 2.5 M | - | 2.42 M | 2.49 M | 2.62 M | - | 2 M | 1.89 M | 1.47 M | - | 1.21 M | 941 K | 779 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung